PFASuiki

7 Questions

PFASuiki: High-tech against perpetual chemicals

PFASuiki has developed a process that completely destroys PFAS – so-called "perpetual chemicals" – directly in the water stream. The Munich-based cleantech startup was founded…

Donexus

Deals

Donexus receives initial funding

Munich-based startup Donexus secures €600,000 from prominent investors to use AI agents to make property management more efficient.

Dyemansion and ASM

Deals

Dyemansion integrates ASM

Dyemansion acquires the Munich-based company ASM. This acquisition expands the 3D printing specialist's post-processing offerings and strengthens its market position…

Smartbax

Deals

Smartbax receives 4.7 million euros

The Munich-based biotech startup Smartbax has secured €4.7 million in a pre-Series A round. The team plans to use the capital to further develop its antibiotics…

Precision

7 Questions

Precision: The new generation of milk

Munich-based foodtech Precision is rethinking milk – with an innovative recipe for plant-based products that taste like cow's milk,…

Munich Founders' Prize

Needs Review

Munich Founders' Prize 2025 goes to InGemeinschaft and Edurino

Stadtsparkasse München has honored the winners of the Munich Founders' Prize 2025: InGemeinschaft wins in the "Startup" category, and Edurino receives the...

Tytan Technologies

Needs Review

Tytan Technologies aims to strengthen Europe’s airspace

The Munich-based startup Tytan Technologies is developing innovative drone defense systems together with Dedrone by Axon and the German Armed Forces. The goal is a networked,…

Slush 2024

Needs Review

Munich Startup is traveling to Slush 2025 with these startups

When Slush 2025 kicks off in Helsinki, Munich Startup will be there again – together with four innovative start-ups from…

Cashwalk

Competition

Cashwalk 2025: Application phase is underway

After 22 successful editions, the Start2 Group's Cashwalk 2025 begins a new round on November 26th – with…

Tubules

Deals

Tubulis receives record sum of 308 million euros

Munich-based biotech Tubulis is working on special antibody drug conjugates (ADCs) for cancer therapy. The company has now secured €308 million in funding…